ISPOR Publishes Report on Health Economics and Outcomes Research in Low- and Middle-Income Countries

Published May 22, 2023

LMIC Report CoverLawrenceville, NJ, USA—May 22, 2023—ISPOR—The Professional Society for Health Economics and Outcomes Research (HEOR) announced today that it has published a new report on its work in low- and middle-income countries (LMICs). The report, “Advancing HEOR in Low- and Middle-Income Countries,” explores the distinctive needs LMICs have in developing their HEOR capacity, as well as the Society’s work to fulfill its mission to promote HEOR excellence to improve decision making for health globally in these regions.

ISPOR has a strong commitment to the advancement of HEOR in LMICs. More than 20% of the Society’s members, 65% of ISPOR regional chapters, and 35% of ISPOR student chapters are in LMICs. The report notes that LMICs face unique healthcare system challenges, “including limited resources for healthcare, gaps in human and infrastructure capacity, often fragmented systems, and growing burden of disease.”

Much of ISPOR’s work in LMICs is focused on supporting critical HEOR capacity building in these countries, through education and training. The Society also provides publishing opportunities for researchers in LMICs, chapter support, conference grants, educational funding, fee-waived membership grants, HEOR awards and more. Additional information can be found on the Society’s Advancing HEOR in Low- and Middle Income Countries webpage.

###


ABOUT ISPOR
ISPOR—The Professional Society for Health Economics and Outcomes Research (HEOR), is an international, multistakeholder, nonprofit dedicated to advancing HEOR excellence to improve decision making for health globally. The Society is the leading source for scientific conferences, peer-reviewed and MEDLINE®-indexed publications, good practices guidance, education, collaboration, and tools/resources in the field.
Website  | LinkedIn  | Twitter (@ispororg)  |  YouTube  |  Facebook  |  Instagram 

Related Stories

Landmark Analysis in Value in Health Uncovers Potential Research Efficiency Gains

Sep 15, 2025

Value in Health, the official journal of ISPOR announced the publication of a landmark scoping review that provides a comprehensive mapping of patient preference studies across key medical domains, revealing the first robust evidence base for advancing meta-analyses and benefit transfer methods in healthcare decision-making.

ISPOR Real-World Evidence Summit 28-30 September 2025 | Tokyo, Japan

Sep 9, 2025

ISPOR announced details for its ISPOR Real-World Evidence Summit 2025: Through The Lens of Asia Pacific. The Summit brings together top experts, decision makers, and industry leaders to explore the latest breakthroughs, share cutting-edge research, and discuss innovative solutions to the region’s most pressing healthcare challenges.

"Most-Favored Nation" Drug Pricing Strategy May Backfire, New Research Warns

Sep 3, 2025

Value in Health, the official journal of ISPOR announced the publication of a new analysis suggesting that the Trump Administration's "Most-Favored Nation" approach to lowering US drug prices by referencing international prices may not achieve its intended goals, based on decades of experience with similar policies in Europe.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×